Tag: IIb

Stock

Roche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s Disease

19/12/2024
admin

PADOVA study showed numerical delay in motor progression and positive trends on multiple secondary and exploratory…